Annual Current Liabilities
$441.00 K
-$148.00 K-25.13%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual total current liabilities is $441.00 thousand, with the most recent change of -$148.00 thousand (-25.13%) on December 31, 2023.
- During the last 3 years, MACK annual current liabilities has fallen by -$329.00 thousand (-42.73%).
Performance
MACK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$22.67 M
+$22.23 M+5041.04%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly total current liabilities is $22.67 million, with the most recent change of +$22.23 million (+5041.04%) on March 1, 2024.
- Over the past year, MACK quarterly current liabilities has increased by +$22.18 million (+4498.78%).
Performance
MACK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MACK Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.1% | +4498.8% |
| 3 y3 years | -42.7% | +4498.8% |
| 5 y5 years | -97.0% | +4498.8% |
MACK Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.1% | at low | at high | -98.2% |
| 5 y | 5-year | -84.1% | at low | at high | -98.2% |
| alltime | all time | -99.6% | at low | -81.3% | -98.2% |
Merrimack Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $22.67 M(+5041.0%) |
| Dec 2023 | $441.00 K(-25.1%) | $441.00 K(-10.5%) |
| Sep 2023 | - | $493.00 K(+20.0%) |
| Jun 2023 | - | $411.00 K(-11.2%) |
| Mar 2023 | - | $463.00 K(-21.4%) |
| Dec 2022 | $589.00 K(+4.8%) | $589.00 K(+31.5%) |
| Sep 2022 | - | $448.00 K(+1.6%) |
| Jun 2022 | - | $441.00 K(-21.8%) |
| Mar 2022 | - | $564.00 K(+0.4%) |
| Dec 2021 | $562.00 K(-27.0%) | $562.00 K(-17.7%) |
| Sep 2021 | - | $683.00 K(-11.5%) |
| Jun 2021 | - | $772.00 K(+12.9%) |
| Mar 2021 | - | $684.00 K(-11.2%) |
| Dec 2020 | $770.00 K(-72.2%) | $770.00 K(-65.3%) |
| Sep 2020 | - | $2.22 M(-5.0%) |
| Jun 2020 | - | $2.33 M(-29.2%) |
| Mar 2020 | - | $3.30 M(+19.0%) |
| Dec 2019 | $2.77 M(-81.3%) | $2.77 M(-41.5%) |
| Sep 2019 | - | $4.74 M(-4.1%) |
| Jun 2019 | - | $4.94 M(-58.2%) |
| Mar 2019 | - | $11.81 M(-20.1%) |
| Dec 2018 | $14.79 M(-25.2%) | $14.79 M(-32.9%) |
| Sep 2018 | - | $22.07 M(+23.3%) |
| Jun 2018 | - | $17.89 M(+2.1%) |
| Mar 2018 | - | $17.53 M(-11.3%) |
| Dec 2017 | $19.78 M | $19.78 M(-42.8%) |
| Sep 2017 | - | $34.56 M(-40.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $57.74 M(-46.5%) |
| Mar 2017 | - | $108.00 M(+22.4%) |
| Dec 2016 | $88.22 M(-15.0%) | $88.22 M(-0.1%) |
| Sep 2016 | - | $88.28 M(-2.9%) |
| Jun 2016 | - | $90.89 M(-6.7%) |
| Mar 2016 | - | $97.36 M(-6.2%) |
| Dec 2015 | $103.75 M(-6.6%) | $103.75 M(+8.9%) |
| Sep 2015 | - | $95.26 M(-12.3%) |
| Jun 2015 | - | $108.61 M(+4.7%) |
| Mar 2015 | - | $103.71 M(-6.7%) |
| Dec 2014 | $111.11 M(+92.5%) | $111.11 M(-8.4%) |
| Sep 2014 | - | $121.23 M(+33.4%) |
| Jun 2014 | - | $90.85 M(+59.4%) |
| Mar 2014 | - | $56.99 M(-1.3%) |
| Dec 2013 | $57.73 M(+49.9%) | $57.73 M(-5.1%) |
| Sep 2013 | - | $60.86 M(+5.4%) |
| Jun 2013 | - | $57.75 M(+19.5%) |
| Mar 2013 | - | $48.31 M(+25.4%) |
| Dec 2012 | $38.52 M(+47.3%) | $38.52 M(+36.6%) |
| Sep 2012 | - | $28.19 M(+5.7%) |
| Jun 2012 | - | $26.67 M(+7.5%) |
| Mar 2012 | - | $24.80 M(-5.1%) |
| Dec 2011 | $26.15 M(+60.2%) | $26.15 M(+11.5%) |
| Sep 2011 | - | $23.46 M(+22.1%) |
| Jun 2011 | - | $19.22 M(-33.5%) |
| Mar 2011 | - | $28.89 M(+77.0%) |
| Dec 2010 | $16.32 M(-80.6%) | $16.32 M |
| Dec 2009 | $84.09 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual current liabilities year-on-year change?
- What is Merrimack Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly current liabilities year-on-year change?
What is Merrimack Pharmaceuticals annual total current liabilities?
The current annual current liabilities of MACK is $441.00 K
What is the all time high annual current liabilities for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual total current liabilities is $111.11 M
What is Merrimack Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, MACK annual total current liabilities has changed by -$148.00 K (-25.13%)
What is Merrimack Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of MACK is $22.67 M
What is the all time high quarterly current liabilities for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly total current liabilities is $121.23 M
What is Merrimack Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, MACK quarterly total current liabilities has changed by +$22.18 M (+4498.78%)